Multiple Molecules See UK Prices More Than Double In December
Pricewatch UK – December 2021
Executive Summary
WaveData’s compilation of the fastest-rising UK generics prices in December showed several products across multiple presentations more than doubling their average trade prices to independent pharmacists.
You may also be interested in...
UK Kicks Off 2022 With Celecoxib And Rizatriptan Rises
UK average trade prices for certain presentations of celecoxib and rizatriptan trebled and even quadrupled in the first month of 2022, according to the latest figures from WaveData.
Blow For Prestige As Trastuzumab Biosimilar Rejected By EMA
Prestige Biopharma has received a setback in its attempts to win a European approval for its HD201 trastuzumab biosimilar rival to Herceptin, after the EMA’s CHMP issued a negative opinion on its parallel marketing authorization applications under the Tuznue and Hervelous labels. Prestige has 15 days in which it can ask for a re-examination of the refusals.
Who’s Hired? Formycon Is Latest To Swap CEO
Formycon has become the latest firm to announce a new CEO, after similar moves at Orion and Strides. Meanwhile, Gedeon Richter has made management changes and a new director has joined Coherus.